Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression-Reference-Cited by-同舟云学术

Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expression

Published:2006-11 Issue:1 Volume:244 Page:34-41
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Badra Filitsa A.,Karamouzis Michalis V.,Ravazoula Panagiota,Likaki-Karatza Eleni,Tzorakoleftherakis Evagelos,Koukouras Dimitrios,Iconomou Gregorios,Xiros Nikolaos,Siablis Dimitrios,Papavassiliou Athanasios G.,Kalofonos Haralabos P.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. The age at which women begin mammographic screening;Colbert;Cancer,2004

2. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening;Tabar;Lancet,2003

3. Mammographic screening: no reliable supporting evidence?;Miettinen;Lancet,2002

4. Breast carcinoma diagnosis, treatment, and prognosis before and after the introduction of mass mammographic screening;Ernst;Cancer,2004

5. Ductal carcinoma in situ of the breast;Burstein;N. Engl J. Med.,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalities;Acta Pharmacologica Sinica;2024-02-15

2. Breast Imaging Findings of Microcalcifications in Ductal Carcinoma in Situ and Their Correlations with Pathological and Biological Features;Iranian Journal of Radiology;2021-11-21

3. Molecular markers, pathology, and ultrasound features of invasive breast cancer;Clinical Imaging;2021-11

4. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer;Academic Radiology;2021-10

5. Mutation profiling in the PIK3CA, TP53, and CDKN2A genes in circulating free DNA and impalpable breast lesions;Annals of Diagnostic Pathology;2019-04